Arguments in favour of excluding MDBGN from the European baseline series. In response to “Comment on MDBGN/DBDCB, the European baseline series, and EU legislation”-Reference-Cited by-同舟云学术

Arguments in favour of excluding MDBGN from the European baseline series. In response to “Comment on MDBGN/DBDCB, the European baseline series, and EU legislation”

Published:2021-08-19 Issue:5 Volume:85 Page:611-613
ISSN:0105-1873
Container-title:Contact Dermatitis
language:en
Short-container-title:Contact Dermatitis

Author:

Mercader‐García Pedro¹^ORCID,Pastor‐Nieto Maria Antonia²^ORCID,Gonzalez‐Perez Ricardo³,Gimenez‐Arnau Ana María⁴^ORCID,Ruiz‐Gonzalez Inmaculada⁵,Mora‐Fernández Verónica⁶,Miquel Javier⁷,Silvestre‐Salvador Juan Francisco⁸^ORCID,Sanz‐Sanchez Tatiana⁹^ORCID,Perez‐Feal Patricia¹⁰,Sánchez‐Pérez Javier¹¹,Heras‐Mendaza Felipe¹²,Serra‐Baldrich Ester¹³,Hervella‐Garces Marcos¹⁴,Gatica‐Ortega María Elena¹⁵^ORCID,García‐Doval Ignacio¹⁶,Borrego Leopoldo¹⁷^ORCID

Affiliation:

1. Dermatology Department Hospital General Universitario Jose Mª Morales Meseguer Murcia Spain

2. Dermatology Department Hospital General Universitario de Guadalajara Guadalajara Spain

3. Dermatology Department Hospital Universitario Araba Vitoria Spain

4. Dermatology Department Hospital del Mar, IMAS Barcelona Spain

5. Dermatology Department Complejo Asistencial Universitario de León Leon Spain

6. Dermatology Department Hospital General Universitari Germans Trias i Pujol Barcelona Spain

7. Dermatology Department Hospital Arnau de Vilanova Valencia Spain

8. Dermatology Department Hospital General Universitario Alicante Spain

9. Dermatology Department Hospital General Universitario Infanta Sofia Madrid Spain

10. Dermatology Department Complejo Hospitalario Universitario Santiago de Compostela Santiago de Compostela Spain

11. Dermatology Department Hospital Universitario La Princesa Madrid Spain

12. Dermatology Department Hospital Fundación Jiménez Diaz Madrid Spain

13. Dermatology Department Hospital de la Santa Creu i Sant Pau Barcelona Spain

14. Dermatology Department Complejo Hospitalario de Navarra Pamplona Spain

15. Dermatology Department Complejo Hospitalario de Toledo Toledo Spain

16. Research Unit Fundación Piel Sana, Academia Española de Dermatología y Venereología Madrid Spain

17. Dermatology Department Complejo Hospitalario Universitario Insular Materno Infantil, Universidad de las Palmas de Gran Canaria Las Palmas de Gran Canaria Spain

Publisher

Wiley

Subject

Dermatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cod.13941

Reference10 articles.

1. Comment on MDBGN/DBDCB, the European baseline series, and EU legislation;Lidén C;Contact Dermatitis,2021

2. Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC national cross‐sectional study

3. Biocidal Products Committee (BPC).https://echa.europa.eu/documents/10162/ee68ecaf‐7d48‐4bb5‐9842‐3dfbb5d3e7a7. Accessed November 29 2020.

4. Effectiveness of European Regulation on Euxyl K400 Sensitization in Northeastern Italy From 1996 to 2012 and Occupation

5. Decreasing trends in methyldibromo glutaronitrile contact allergy – following regulatory intervention

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High prevalence but no current clinical relevance of methyldibromo glutaronitrile since its ban in Turkey in 2015;Contact Dermatitis;2024-07-21

2. Patch test results with the European baseline series, 2019/20—Joint European results of the ESSCA and the EBS working groups of the ESCD , and the GEIDAC;Contact Dermatitis;2022-06-24

3. Aktuelles zu den Epikutantestreihen der Deutschen Kontaktallergie-Gruppe – Update Januar 2022;Dermatologie in Beruf und Umwelt;2022-01-01

4. Reply to further response: Comment on MDBGN / DBDCB , the European baseline series, and EU legislation—Again;Contact Dermatitis;2021-08-06